Galaxy Surfactants Ltd. · NSE:GALAXYSURF

Galaxy Surfactants — Q2 FY26 Earnings Presentation

17 slides from Galaxy Surfactants's earnings presentation, Nov 12, 2025

  1. Slide 1: Exchange filing cover letter for investor presentation

    November 12, 2025 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub: Investor presentation

  2. Slide 2: Galaxy Surfactants Limited Result Presentation November'25

    Galaxy Surfactants Limited Result Presentation November’25

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se

  4. Slide 4: Company at a Glance

    Company at a Glance Extensive R&D Capabilities 7 Strategically Located 215+ Product Grades Facilities with Inhouse 100+ Members Project Execution Capabilities Performance Surfactants: 47+ R&D Centre Specialty Care Products: 168+ Pilot Plant 5 in India Product Application Centre 1 in Egypt 1 in US Pr

  5. Slide 5: Q2 & H1FY26 Performance Highlights

    Q2 & H1FY26 Performance Highlights

  6. Slide 6: Q2FY26: Key Developments

    Q2FY26: Key Developments 1 Volumes remained broadly flat on both YoY and QoQ basis 4 India Volume remained flat YoY and QoQ basis EBITDA declined by 5% YoY in H1FY26 and 15% QoQ in Q2FY26, primarily due to global tariff headwinds, 2 tactical reformulation within the Performance segment and lower dom

  7. Slide 7: Management Commentary

    Management Commentary “Q2FY26 volumes remained broadly flat on both YoY and QoQ basis, reflecting short-term turbulence across markets. Specialty segment delivered strong double-digit growth, offsetting a higher single-digit decline in the Performance segment. India’s domestic performance faced temp

  8. Slide 8: H1FY26: Segment Performance Highlights

    H1FY26: Segment Performance Highlights Segment-wise Revenue & Volume Performance Performance Surfactants Revenue Specialty Care Revenue Total Revenue ₹ 1,681.4 cr ₹ 939.7 cr ₹ 2,621.1cr Overall Volume growth remains Low Single digit on YoY Region-wise Volume Performance INDIA AMET ROW Low single dig

  9. Slide 9: Q2 & H1FY26: Revenue Performance

    Q2 & H1FY26: Revenue Performance Category Customer Region wise Revenue 40% 45% 41% 44% 49% 48% 50% 48% 61% 63% 60% 64% 11% 8% 9% 23% 23% 11% 21% 21% 39% 40% 40% 44% 39% 43% 37% 36% 37% 34% 36% 34% Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Performance Surfact

  10. Slide 10: Managing Volatility in Raw Material Prices and Currency

    Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 90.00 3,000 86.00 2,600 2,200 82.00 1,800 78.00 1,400 74.00 1,000 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LOR Source: RB

  11. Slide 11: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Particulars (Rs. In Crores) Q2FY26 Q2FY25 Y-o-Y H1FY26 H1FY25 Y-o-Y Net Revenue from Operations 1,326.2 1,063.0 24.8% 2,604.1 2,037.1 27.8% Other Income 5.8 8.7 17.0 14.1 Total Revenue 1,332.0 1,071.7 24.3% 2,621.1 2,051.1 27.8% Cost of Material Consumed 1,001.3

  12. Slide 12: Consolidated Balance Sheet

    Consolidated Balance Sheet Particulars (Rs. In Crores) Sep'25 Mar'25 Particulars (Rs. In Crores) Sep'25 Mar'25 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 834.9 839.8 EQUITY Right-of-use assets 187.5 184.3 Equity Share Capital 35.5 35.5 Capital work-in-progress 289.9 261.9 Other Equi

  13. Slide 13: Consolidated Cashflow Statement

    Consolidated Cashflow Statement Particulars (Rs. In Crores) H1FY26 H1FY25 Cash Flow From Operating Activities : Profit After Tax 146.0 164.4 Operating Profit before working Capital changes 241.0 252.3 Net cash flows generated from/(used) in Operating Activities (A) 169.4 243.3 Net cash flows generat

  14. Slide 14: Standalone Profit & Loss Statement

    Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q2FY26 Q2FY25 Y-o-Y H1FY26 H1FY25 Y-o-Y Net Revenue from Operations 919.0 782.2 17.5% 1,793.0 1,459.7 22.8% Other Income 13.1 13.2 19.5 14.2 Total Revenue 932.0 795.4 17.2% 1,812.6 1,473.9 23.0% Cost of Material Consumed 717.8 549.6 1,39

  15. Slide 15: Standalone Balance Sheet

    Standalone Balance Sheet Particulars (Rs. In Crores) Sep'25 Mar'25 Particulars (Rs. In Crores) Sep'25 Mar'25 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 545.2 553.5 EQUITY Right-of-use assets 150.0 145.4 Equity Share Capital 35.5 35.5 Capital work-in-progress 287.1 253.9 Other Equity

  16. Slide 16: Standalone Cashflow Statement

    Standalone Cashflow Statement Particulars (Rs. In Crores) H1FY26 H1FY25 Cash Flow From Operating Activities : Profit After Tax 88.2 100.4 Operating Profit before working Capital changes 144.9 152.2 Net cash flows generated from/(used) in Operating Activities (A) 18.2 191.6 Net cash flows generated f

  17. Slide 17: Thank You

    Thank You Company Investor Relations Advisors : CIN - U74140MH2010PTC204285 CIN No: L39877MH1986PLC039877 Mr. Mandar Chavan / Mr. Rahul Agarwal Mr. Ruchir Soni mandar.chavan@sgapl.net / Email: Ruchir.Soni@galaxysurfactants.com rahul.agarwal@sgapl.net www.galaxysurfactants.com +91 96993 82195 / +91 9

Galaxy Surfactants — Q2 FY26 Earnings Presentation on 6ix